Zhang Lu, Li Chu-Xin, Wan Shuang-Shuang, Zhang Xian-Zheng
Key Laboratory of Biomedical Polymers of Ministry of Education and Department of Chemistry, Wuhan University, Wuhan, 430072, P. R. China.
National and Local Joint Engineering Research Center of Biodiagnosis and Biotherapy, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, 710004, P. R. China.
Adv Healthc Mater. 2022 Jan;11(2):e2101971. doi: 10.1002/adhm.202101971. Epub 2021 Nov 17.
Traditional tumor treatments, including chemotherapy, radiotherapy, photodynamic therapy, and photothermal therapy, are developed and used to treat different types of cancer. Recently, chemodynamic therapy (CDT) has been emerged as a novel cancer therapeutic strategy. CDT utilizes Fenton or Fenton-like reaction to generate highly cytotoxic hydroxyl radicals (•OH) from endogenous hydrogen peroxide (H O ) to kill cancer cells, which displays promising therapeutic potentials for tumor treatment. However, the low catalytic efficiency and off-target side effects of Fenton reaction limit the biomedical application of CDT. In this regard, various strategies are implemented to potentiate CDT against tumor, including retrofitting the tumor microenvironment (e.g., increasing H O level, decreasing reductive substances, and reducing pH), enhancing the catalytic efficiency of nanocatalysts, and other strategies. This review aims to summarize the development of CDT and summarize these recent progresses of nanocatalyst-mediated CDT for antitumor application. The future development trend and challenges of CDT are also discussed.
传统的肿瘤治疗方法,包括化疗、放疗、光动力疗法和光热疗法,已被开发并用于治疗不同类型的癌症。近年来,化学动力疗法(CDT)已成为一种新型的癌症治疗策略。CDT利用芬顿或类芬顿反应,从内源性过氧化氢(H₂O₂)中产生具有高度细胞毒性的羟基自由基(•OH)来杀死癌细胞,这为肿瘤治疗显示出了有前景的治疗潜力。然而,芬顿反应的低催化效率和脱靶副作用限制了CDT在生物医学中的应用。在这方面,人们实施了各种策略来增强CDT对肿瘤的作用,包括改造肿瘤微环境(例如,提高H₂O₂水平、减少还原性物质和降低pH值)、提高纳米催化剂的催化效率以及其他策略。本综述旨在总结CDT的发展,并概述纳米催化剂介导的CDT在抗肿瘤应用中的这些最新进展。还讨论了CDT的未来发展趋势和挑战。
Adv Healthc Mater. 2022-1
ACS Appl Mater Interfaces. 2021-11-17
Acta Biomater. 2022-7-15
Adv Healthc Mater. 2024-9
J Nanobiotechnology. 2022-2-5
Int J Nanomedicine. 2025-5-20
Int J Nanomedicine. 2025-5-1
J Hematol Oncol. 2025-4-17
Pharmaceutics. 2025-2-26
Cancers (Basel). 2024-10-24